Orbimed Advisors Llc
10% Owner at Adicet Bio, Inc. (ACET); 10% Owner at Enliven Therapeutics, Inc. (ELVN); Director at Scribe Therapeutics, Inc. (SCTX); Director at Sionna Therapeutics, Inc. (SION)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 29SEC | SCTXScribe Therapeutics, Inc. | Buy | 1,000,0001,348,825 held (+287%) | $15.00 | $15.0M | +41.1% |
| Jul 2SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 115,8442,555,877 held (−4%) | $45.50 | $5.3M | -89.2% |
| Jun 24SEC | ELVNEnliven Therapeutics, Inc. | Sell | 24,846220,882 held (−10%) | $45.38 | $1.1M | -9.7% |
| Jun 24SEC | ELVNEnliven Therapeutics, Inc. | Sell | 1,477219,405 held (−1%) | $45.00 | $66K | -8.9% |
| Jun 24SEC | ELVNEnliven Therapeutics, Inc. | Sell | 787,0246,601,878 held (−11%) | $45.38 | $35.7M | -9.7% |
| Jun 24SEC | ELVNEnliven Therapeutics, Inc. | Sell | 46,7766,555,102 held (−1%) | $45.00 | $2.1M | -8.9% |
| Jun 17SEC | ELVNEnliven Therapeutics, Inc. | Sell | 9,086245,728 held (−4%) | $45.02 | $409K | -9.0% |
| Jun 17SEC | ELVNEnliven Therapeutics, Inc. | Sell | 272,3227,388,902 held (−4%) | $45.02 | $12.3M | -9.0% |
| May 29SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 1012,671,721 held (−0%) | $44.49 | $4K | -89.0% |
| May 11SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 48,5462,916,228 held (−2%) | $44.61 | $2.2M | -89.0% |
| May 11SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 59,7672,856,461 held (−2%) | $44.58 | $2.7M | -89.0% |
| May 11SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 184,6392,671,822 held (−6%) | $46.22 | $8.5M | -89.4% |
| Apr 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 52,3972,967,722 held (−2%) | $44.68 | $2.3M | -89.0% |
| Apr 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 2,9482,964,774 held (−0%) | $44.52 | $131K | -89.0% |
| Apr 16SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 47,8143,482,888 held (−1%) | $44.51 | $2.1M | -89.0% |
| Apr 16SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 235,8633,247,025 held (−7%) | $44.64 | $10.5M | -89.0% |
| Apr 16SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 226,9063,020,119 held (−7%) | $45.34 | $10.3M | -89.2% |
| Nov 26SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 94,5833,610,376 held (−3%) | $44.54 | $4.2M | -89.0% |
| Nov 26SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 11,8903,598,486 held (−0%) | $44.60 | $530K | -89.0% |
| Nov 26SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 1,6003,596,886 held (−0%) | $44.49 | $71K | -89.0% |
| Oct 10SEC | ACETAdicet Bio, Inc. | Buy | 1,500,0009,026,359 held (+20%) | $1.00 | $1.5M | +461.0% |
| Oct 10SEC | ACETAdicet Bio, Inc. | Buy | 3,500,0004,490,254 held (+353%) | $1.00 | $3.5M | +461.0% |
- Buy
Director Orbimed Advisors Llc bought $15.0M of SCTX at $15.00 — first open-market purchase in our records; raises the stake by 287%.
- Sell
Director Orbimed Advisors Llc sold $5.3M of SION at $45.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Orbimed Advisors Llc sold $4K of SION at $44.49 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Orbimed Advisors Llc sold $2.2M of SION at $44.61 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Orbimed Advisors Llc sold $2.7M of SION at $44.58 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Orbimed Advisors Llc sold $8.5M of SION at $46.22 — pre-scheduled 10b5-1 plan sale.